GUANGZHOU JET BIO-FILTRATION CO., LTD. Guangzhou Jet Bio-Filtration Co., Ltd. Stock
Equities
688026
CNE100003RQ9
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.19 CNY | +2.94% |
|
+14.18% | -35.09% |
| Sales 2024 * | 549M 75.77M | Sales 2025 * | 661M 91.22M | Capitalization | 1.57B 217M |
|---|---|---|---|---|---|
| Net income 2024 * | 62M 8.56M | Net income 2025 * | 78M 10.76M | EV / Sales 2024 * | 2.86 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.38 x |
| P/E ratio 2024 * |
25.1
x | P/E ratio 2025 * |
20.2
x | Employees | 1,317 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 44.11% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.94% | ||
| 1 week | +14.18% | ||
| Current month | -5.97% | ||
| 1 month | -3.62% | ||
| 3 months | -20.07% | ||
| 6 months | -31.22% | ||
| Current year | -35.09% |
1 week
9.73
11.33
1 month
9.0112.30
Current year
8.1017.59
1 year
8.1020.77
3 years
8.1070.63
5 years
8.10112.14
10 years
8.10112.14
| Managers | Title | Age | Since |
|---|---|---|---|
Ye Yuan
CEO | Chief Executive Officer | 45 | 04-12-31 |
Jian Hua Yuan
FOU | Founder | 72 | 01-04-10 |
Xiang Yuan Fang
CTO | Chief Tech/Sci/R&D Officer | 52 | 01-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Zhi Chun Liu
BRD | Director/Board Member | 52 | 19-01-14 |
Jian Hua Yuan
FOU | Founder | 72 | 01-04-10 |
Ye Yuan
CEO | Chief Executive Officer | 45 | 04-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | +1.11% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 11.19 | +2.94% | 2,195,517 |
| 24-04-25 | 10.87 | +2.64% | 1,780,583 |
| 24-04-24 | 10.59 | +1.53% | 2,228,220 |
| 24-04-23 | 10.43 | -5.18% | 3,241,512 |
| 24-04-22 | 11 | +12.24% | 3,715,260 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotes
Guangzhou Jet Biofiltration Co., Ltd. is a China-based company mainly engaged in the research, development, manufacture and sales of biological laboratory consumable products. The Company focuses on disposable plastic consumables for cell culture and related liquid handling biological laboratories. Its main products include biological culture type and liquid handling type, as well as reagents and small laboratory equipment. The Company distributes its products in domestic and to overseas markets.
Calendar
2024-04-26
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
11.19
CNY
Average target price
14
CNY
Spread / Average Target
+25.11%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -35.09% | 211M | |
| -2.31% | 185B | |
| -3.20% | 105B | |
| -5.04% | 66.59B | |
| +0.20% | 54.66B | |
| +17.29% | 47.78B | |
| +4.06% | 41.26B | |
| +2.36% | 26.95B | |
| +2.07% | 26.37B | |
| +12.96% | 24.8B |
- Stock Market
- Equities
- 688026 Stock
